Nierenberg, A., Lavin, P., Javitt, D. C., Shelton, R., Sapko, M. T., Mathew, S., Besthof, R. E., & Javitt, J. C. (2023). NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial. International Journal of Bipolar Disorders, 11(1). https://doi.org/10.1186/s40345-023-00308-5